Norges Bank Ironwood Pharmaceuticals Inc Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

49 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$5.58 - $8.61 $7.77 Million - $12 Million
1,393,077 New
1,393,077 $9.08 Million
Q4 2023

Feb 09, 2024
BUY
$8.79 - $11.51 $7.16 Million - $9.38 Million
814,774 New
814,774 $9.32 Million
Q3 2023

Nov 13, 2024
BUY
$8.25 - $11.35 $7.58 Million - $10.4 Million
919,049 New
919,049 $8.85 Million
Q3 2023

Nov 13, 2023
SELL
$8.25 - $11.35 $12.2 Million - $16.8 Million
-1,483,774 Closed
0 $0
Q2 2023

Aug 14, 2024
SELL
$10.1 - $11.6 $2.72 Million - $3.12 Million
-269,256 Reduced 19.33%
1,123,821 $12 Million
Q2 2023

Aug 14, 2023
SELL
$10.1 - $11.6 $14.5 Million - $16.7 Million
-1,437,734 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$10.37 - $12.56 $15.9 Million - $19.3 Million
1,536,774 New
1,536,774 $16.2 Million
Q4 2022

Feb 14, 2023
BUY
$9.9 - $12.43 $15.1 Million - $18.9 Million
1,521,628 New
1,521,628 $18.9 Million
Q3 2022

Nov 13, 2023
BUY
$10.14 - $12.38 $15 Million - $18.4 Million
1,483,774 New
1,483,774 $15.4 Million
Q2 2022

Aug 14, 2023
BUY
$11.05 - $12.72 $15.9 Million - $18.3 Million
1,437,734 New
1,437,734 $16.6 Million
Q1 2022

May 12, 2023
BUY
$10.61 - $12.88 $16.2 Million - $19.7 Million
1,530,093 Added 100.56%
3,051,721 $38.4 Million
Q1 2022

May 09, 2022
SELL
$10.61 - $12.88 $32 Million - $38.9 Million
-3,016,328 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$10.86 - $13.95 $32.8 Million - $42.1 Million
3,016,328 New
3,016,328 $35.2 Million
Q3 2021

Nov 14, 2022
BUY
$11.92 - $13.92 $21.2 Million - $24.7 Million
1,775,428 New
1,775,428 $23.2 Million
Q3 2021

Nov 05, 2021
SELL
$11.92 - $13.92 $21.2 Million - $24.8 Million
-1,781,953 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$10.16 - $13.11 $18.1 Million - $23.4 Million
1,781,953 New
1,781,953 $22.9 Million
Q2 2021

Aug 10, 2021
SELL
$10.16 - $13.11 $18.4 Million - $23.7 Million
-1,807,569 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$9.04 - $11.86 $16.3 Million - $21.4 Million
1,807,569 New
1,807,569 $20.2 Million
Q1 2021

May 07, 2021
SELL
$9.04 - $11.86 $18.6 Million - $24.3 Million
-2,052,390 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$9.05 - $12.2 $18.6 Million - $25 Million
2,052,390 New
2,052,390 $23.4 Million
Q4 2020

Feb 10, 2021
SELL
$9.05 - $12.2 $18.6 Million - $25 Million
-2,052,390 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$8.99 - $10.74 $18.5 Million - $22 Million
2,052,390 New
2,052,390 $18.5 Million
Q3 2020

Nov 10, 2020
SELL
$8.99 - $10.74 $22.2 Million - $26.5 Million
-2,471,979 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$9.14 - $11.97 $22.6 Million - $29.6 Million
2,471,979 New
2,471,979 $25.5 Million
Q2 2020

Aug 07, 2020
SELL
$9.14 - $11.97 $23 Million - $30.1 Million
-2,515,848 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$8.58 - $14.01 $21.6 Million - $35.2 Million
2,515,848 New
2,515,848 $25.4 Million
Q1 2020

May 08, 2020
SELL
$8.58 - $14.01 $22.1 Million - $36.1 Million
-2,577,122 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$8.22 - $14.0 $21.2 Million - $36.1 Million
2,577,122 New
2,577,122 $34.3 Million
Q4 2019

Feb 12, 2020
SELL
$8.22 - $14.0 $21.2 Million - $36.1 Million
-2,577,122 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$8.59 - $10.96 $22.1 Million - $28.2 Million
2,577,122 New
2,577,122 $22.1 Million
Q3 2019

Nov 08, 2019
SELL
$8.59 - $10.96 $20.9 Million - $26.6 Million
-2,431,240 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$9.8 - $12.89 $23.8 Million - $31.3 Million
2,431,240 New
2,431,240 $26.6 Million
Q2 2019

Aug 09, 2019
SELL
$9.8 - $12.89 $20.3 Million - $26.8 Million
-2,076,243 Closed
0 $0
Q1 2019

May 11, 2020
BUY
$8.27 - $12.73 $1.55 Million - $2.39 Million
187,434 Added 9.92%
2,076,243 $28.1 Million
Q4 2018

Mar 04, 2019
BUY
$7.8 - $16.13 $14.7 Million - $30.5 Million
1,888,809 New
1,888,809 $19.6 Million
Q4 2018

Feb 08, 2019
SELL
$7.8 - $16.13 $11.2 Million - $23.3 Million
-1,441,994 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$14.31 - $17.65 $20.6 Million - $25.5 Million
1,441,994 New
1,441,994 $26.6 Million
Q3 2018

Nov 09, 2018
SELL
$14.31 - $17.65 $16 Million - $19.7 Million
-1,117,833 Closed
0 $0
Q2 2018

Aug 12, 2019
BUY
$11.83 - $16.2 $13.2 Million - $18.1 Million
1,117,833 New
1,117,833 $21.4 Million
Q2 2018

Jul 23, 2018
SELL
$11.83 - $16.2 $11.9 Million - $16.2 Million
-1,003,056 Closed
0 $0
Q1 2018

May 15, 2019
BUY
$11.13 - $13.63 $11.2 Million - $13.7 Million
1,003,056 New
1,003,056 $15.5 Million
Q1 2018

May 09, 2018
SELL
$11.13 - $13.63 $26.2 Million - $32 Million
-2,350,397 Closed
0 $0
Q4 2017

Mar 05, 2018
BUY
$12.16 - $14.58 $28.6 Million - $34.3 Million
2,350,397 New
2,350,397 $35.2 Million
Q4 2017

Feb 09, 2018
SELL
$12.16 - $14.58 $24.5 Million - $29.4 Million
-2,013,390 Closed
0 $0
Q3 2017

Nov 13, 2018
BUY
$12.07 - $14.87 $24.3 Million - $29.9 Million
2,013,390 New
2,013,390 $31.8 Million
Q3 2017

Nov 07, 2017
SELL
$12.07 - $14.87 $26.5 Million - $32.6 Million
-2,191,837 Closed
0 $0
Q2 2017

Jul 24, 2018
BUY
N/A
587,533 Added 36.62%
2,191,837 $41.4 Million
Q1 2017

May 11, 2018
BUY
N/A
543,762 Added 51.27%
1,604,304 $27.4 Million
Q3 2016

Nov 13, 2017
BUY
N/A
1,060,542
1,060,542 $0

Others Institutions Holding IRWD

# of Institutions
238
Shares Held
162M
Call Options Held
11.2M
Put Options Held
9.1K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $541M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email